Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
Status:
Active, not recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well simvastatin works in preventing liver cancer
in patients with liver cirrhosis. Simvastatin may stop the growth of cancer cells by blocking
some of the enzymes needed for cell growth.